| P50 | author | Jeverson Moreira | Q60492935 |
| | Pierre Alexis Geoffroy | Q39061913 |
| P2860 | cites work | Grand challenges in global mental health | Q22251122 |
| | Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication | Q22253024 |
| | A molecular mechanism for the effect of lithium on development | Q24629067 |
| | Circadian genes, rhythms and the biology of mood disorders | Q24669771 |
| | Melatonin biosynthesis: the structure of serotonin N-acetyltransferase at 2.5 A resolution suggests a catalytic mechanism | Q27639788 |
| | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860537 |
| | Effect of Lithium on Circadian Neurotransmitter Receptor Rhythms | Q49127781 |
| | Polymorphism of circadian clock genes and prophylactic lithium response. | Q50709421 |
| | Egr1 regulates lithium-induced transcription of the Period 2 (PER2) gene. | Q50865918 |
| | Effects of chronic lithium treatment on retinal electrophysiologic function. | Q50968268 |
| | Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients. | Q51794510 |
| | Lithium lengthens circadian period but fails to counteract behavioral helplessness in rats. | Q52235715 |
| | Effects of lithium chloride on sleep patterns in the rat | Q52308197 |
| | Melatonin suppression by light in euthymic bipolar and unipolar patients. | Q52539468 |
| | Interacting genes in lithium prophylaxis: preliminary results of an exploratory analysis on the role of DGKH and NR1D1 gene polymorphisms in 199 Sardinian bipolar patients. | Q54716070 |
| | Coordination of circadian timing in mammals | Q27860673 |
| | A molecular mechanism regulating rhythmic output from the suprachiasmatic circadian clock | Q28589294 |
| | Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells | Q29618245 |
| | Lithium lengthens the circadian period of individual suprachiasmatic nucleus neurons | Q30306255 |
| | The effects of lithium on a neuronal in vitro circadian pacemaker | Q30466793 |
| | Mania-like behavior induced by disruption of CLOCK | Q30479252 |
| | Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. | Q31855623 |
| | The social zeitgeber theory, circadian rhythms, and mood disorders: review and evaluation | Q33253691 |
| | Regulation of BMAL1 protein stability and circadian function by GSK3beta-mediated phosphorylation. | Q33521907 |
| | Role of melanopsin in circadian responses to light | Q34164611 |
| | A survey of genomic studies supports association of circadian clock genes with bipolar disorder spectrum illnesses and lithium response | Q34182250 |
| | Lithium impacts on the amplitude and period of the molecular circadian clockwork. | Q34200717 |
| | Combination therapy for manic phases: a critical review of a common practice | Q34308027 |
| | Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock | Q34495384 |
| | Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder | Q34540294 |
| | Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). | Q34564599 |
| | The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania | Q34606256 |
| | A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder. | Q34648457 |
| | Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study | Q34923924 |
| | AKT kinase activity is required for lithium to modulate mood-related behaviors in mice. | Q34988406 |
| | Lithium ameliorates nucleus accumbens phase-signaling dysfunction in a genetic mouse model of mania. | Q35190460 |
| | Rhythms and the pharmacology of lithium | Q35217626 |
| | Circadian rhythms and mood regulation: insights from pre-clinical models | Q35230752 |
| | Circadian biomarkers in patients with bipolar disorder: promising putative predictors of lithium response | Q35661570 |
| | Circadian rhythmicity of active GSK3 isoforms modulates molecular clock gene rhythms in the suprachiasmatic nucleus | Q36100556 |
| | Which clinical factors predict response to prophylactic lithium? A systematic review for bipolar disorders | Q36263641 |
| | Toward constructing an endophenotype strategy for bipolar disorders | Q36365584 |
| | Calcium channel genes associated with bipolar disorder modulate lithium's amplification of circadian rhythms. | Q36378252 |
| | Circadian acetylome reveals regulation of mitochondrial metabolic pathways | Q36653760 |
| | An important role for cholecystokinin, a CLOCK target gene, in the development and treatment of manic-like behaviors | Q37198810 |
| | Genetic and clinical factors predict lithium's effects on PER2 gene expression rhythms in cells from bipolar disorder patients | Q37281130 |
| | Looking at lithium: molecular moods and complex behaviour | Q37327911 |
| | Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade | Q37416273 |
| | Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology | Q37426143 |
| | Circadian rhythms and sleep in bipolar disorder | Q37780286 |
| | Genetics of circadian rhythms and mood spectrum disorders | Q37915783 |
| | Impact of psychotropic drugs on suicide and suicidal behaviors | Q38122748 |
| | Can the response to mood stabilizers be predicted in bipolar disorder? | Q38175696 |
| | The action of lithium carbonate on the sleep-waking cycle in the cat | Q39431711 |
| | Functional genetic variation in the Rev-Erbα pathway and lithium response in the treatment of bipolar disorder. | Q39502405 |
| | Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta -50 T/C SNP. | Q40448135 |
| | Effect of lithium on rod photoreceptor rhodopsin-coupled G-protein (transducin) | Q41107902 |
| | Effect of chronic lithium treatment on twenty four hour variation in plasma and red blood cell lithium and sodium concentrations, drinking behavior, body weight, kidney weight, and corticosterone levels | Q41555482 |
| | Lithium promotes entrainment of rats to long circadian light-dark cycles | Q41601054 |
| | Lithium delays biochemical circadian rhythms in rats | Q41601466 |
| | Lithium and circadian patterns of melatonin in the retina, hypothalamus, pineal and serum | Q42117995 |
| | A neurophysiological study of a lithium-sensitive phosphoinositide system in the hamster suprachiasmatic (SCN) biological clock in vitro | Q42452330 |
| | A role for glycogen synthase kinase-3beta in the mammalian circadian clock | Q42813340 |
| | Lithium differentially affects clock gene expression in serum-shocked NIH-3T3 cells. | Q42820605 |
| | Nuclear receptor rev-erb-{alpha} circadian gene variants and lithium carbonate prophylaxis in bipolar affective disorder | Q43116289 |
| | Relapse and impairment in bipolar disorder | Q43514252 |
| | Glycogen synthase kinase-3β haploinsufficiency lengthens the circadian locomotor activity period in mice | Q44254730 |
| | Effect of lithium on the circadian rhythms of locomotor activity and glycogen synthase kinase-3 protein expression in the mouse suprachiasmatic nuclei | Q44847940 |
| | Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. | Q45484599 |
| | Real-time in vivo monitoring of circadian E-box enhancer activity: a robust and sensitive zebrafish reporter line for developmental, chemical and neural biology of the circadian clock. | Q45931271 |
| | The pharmacogenetics of lithium response depends upon clinical co-morbidity. | Q45959644 |
| | Lithium- and valproate-induced alterations in circadian locomotor behavior in Drosophila | Q46547626 |
| | Lithium affects REM sleep occurrence, autonomic activity and brain second messengers in the rat. | Q46928310 |
| | A role for the segment polarity gene shaggy/GSK-3 in the Drosophila circadian clock | Q47070465 |
| | Lithium in pigmented eye rats: effects of dose and time of day on drinking, body weight, retinal and blood distribution | Q47244931 |
| | Effects of lithium on circadian cycles in food and water intake, urinary concentration and body weight in rats. | Q47269499 |
| | Glycogen synthase kinase 3beta as a likely target for the action of lithium on circadian clocks | Q47641512 |
| | Alcohol and lithium have opposing effects on the period and phase of the behavioral free-running activity rhythm | Q47982371 |
| | Influence of lithium salts on chick pineal gland melatonin secretion | Q48106753 |
| | Effects of lithium on dopamine behavioural supersensitivity induced by rapid eye movement sleep deprivation | Q48162913 |
| | Ongoing lithium treatment prevents relapse after total sleep deprivation. | Q48197910 |
| | Lithium and rhythms of beta-adrenergic ([3H]CGP-12177) binding in intact rat retina, pineal gland, and hypothalamus | Q48203881 |
| | Lithium lengthens the period of circadian rhythms in lesioned hamsters bearing SCN grafts. | Q48260473 |
| | Response of rat pineal melatonin to calcium, magnesium, and lithium is circadian stage dependent | Q48327205 |
| | Lithium effects on selected circadian rhythms in rats | Q48455240 |
| | Mice with neuron-specific accumulation of mitochondrial DNA mutations show mood disorder-like phenotypes | Q48581868 |
| | Total sleep deprivation combined with lithium and light therapy in the treatment of bipolar depression: replication of main effects and interaction. | Q48717410 |
| | Valproic acid phase shifts the rhythmic expression of Period2::Luciferase. | Q48730387 |
| | Decreased sensitivity to light of the photic entrainment pathway during chronic clorgyline and lithium treatments | Q48789002 |
| | Effects of chronic lithium, clorgyline, imipramine, fluphenazine and constant darkness on the alpha-melanotropin content and circadian rhythm in rat brain | Q48873964 |
| | Clinical and pathogenic aspects of candidate genes for lithium prophylactic efficacy | Q48918376 |
| | Lithium lengthens circadian period in a diurnal primate, Saimiri sciureus | Q48922441 |
| | Disk-shedding in the rat retina: lithium dampens the circadian rhythm but potentiates the light response | Q48932797 |
| | Lithium increases slow wave sleep: possible mediation by brain 5-HT2 receptors? | Q48950246 |
| | Chronic lithium prevents REM sleep deprivation-induced increased responsiveness to apomorphine | Q49048458 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | circadian rhythm | Q208353 |
| | bipolar disorder | Q131755 |
| P304 | page(s) | 351-373 | |
| P577 | publication date | 2016-03-22 | |
| P1433 | published in | Chronobiology International | Q2025696 |
| P1476 | title | Lithium and bipolar disorder: Impacts from molecular to behavioural circadian rhythms | |
| P478 | volume | 33 | |